AEPCX
Price
$51.92
Change
-$1.50 (-2.81%)
Updated
Apr 3 closing price
Net Assets
125.35B
BGCJX
Price
$14.12
Change
-$0.32 (-2.22%)
Updated
Apr 3 closing price
Net Assets
246.54M
Ad is loading...

AEPCX vs BGCJX

Header iconAEPCX vs BGCJX Comparison
Open Charts AEPCX vs BGCJXBanner chart's image
American Funds Europacific Growth C
Price$51.92
Change-$1.50 (-2.81%)
VolumeN/A
Net Assets125.35B
Baillie Gifford EAFE Plus All Cap 3
Price$14.12
Change-$0.32 (-2.22%)
VolumeN/A
Net Assets246.54M
AEPCX vs BGCJX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. BGCJX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and BGCJX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 125B vs. BGCJX (247M). BGCJX pays higher dividends than AEPCX: BGCJX (4.42) vs AEPCX (0.35). AEPCX was incepted earlier than BGCJX: AEPCX (24 years) vs BGCJX (5 years). AEPCX (1.59) is less costly to investors than BGCJX (0.56). AEPCX is a more actively managed with annual turnover of: 30.00 vs. BGCJX (16.00). AEPCX has a lower initial minimum investment than BGCJX: AEPCX (250) vs BGCJX (100000000). BGCJX annual gain was more profitable for investors over the last year : -2.64 vs. AEPCX (-7.70).
AEPCXBGCJXAEPCX / BGCJX
Total Expense Ratio1.590.56284%
Annual Report Gross Expense Ratio1.590.56284%
Fund Existence24 years5 years-
Gain YTD0.4840.97650%
Front LoadN/AN/A-
Min. Initial Investment2501000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets125B247M50,607%
Annual Yield % from dividends0.354.428%
Returns for 1 year-7.70-2.64292%
Returns for 3 years-6.24-10.2861%
Returns for 5 years32.00N/A-
Returns for 10 years6.54N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REVB2.810.14
+5.24%
Revelation Biosciences Inc
SLS1.100.01
+0.92%
SELLAS Life Sciences Group
NIO3.74-0.06
-1.58%
NIO Inc.
RAMP25.23-1.38
-5.19%
LiveRamp Holdings
CEVA22.55-3.66
-13.96%
CEVA